Introduction
============

The 1,3-dipolar azide--alkyne cycloaddition (AAC) has been effective for the synthesis of a wide variety of 1,2,3-triazoles \[[@R1]\]. However, this reaction has some limitations such as the requirement of high temperature and the generation of regioisomers. In 2002 Sharpless \[[@R2]\] and Meldal \[[@R3]\] independently reported that the addition of catalytic amounts of copper reagent in the AAC allow the reaction to proceed under milder reaction conditions, and there was also an effect on the regioselectivity for the synthesis of 1,4-disubstituted 1,2,3-triazoles. Since then, the CuAAC has been widely applied in organic synthesis \[[@R4]--[@R12]\], molecular biology \[[@R13]--[@R17]\], and materials science \[[@R18]--[@R20]\]. There are many reports of CuAACs by using terminal alkynes (including metal acetylides) \[[@R4]--[@R20]\]. But the use of internal alkynes in CuAACs for the synthesis of 1,4,5-trisubstituted 1,2,3-triazoles is a more challenging area because of the difficulty in regiocontrol based on the increased steric hindrance \[[@R21]--[@R22]\]. A regioselective CuAAC synthesis of fully substituted 1,2,3-triazoles having group 15 (P, Bi) elements as substituents at the C-5 position was recently attempted. Li et al. reported that the cycloaddition of alkynylphosphonate with benzyl azide did not generate 1,2,3-triazolyl-5-phosphonates, but a three-component reaction of a terminal alkyne, an organic azide, and an H-phosphate in the presence of CuCl~2~ (10 mol %) and triethylamine (2 equiv) afforded the desired 1,2,3-triazolyl-5-phosphonates \[[@R23]\]. Fokin et al. carried out the reaction of ethynylbismuthane with organic azides using CuOTf (5 mol %) and isolated 5-bismuthano-1,2,3-triazoles (Bi), which could be employed as versatile building blocks in chemical synthesis \[[@R24]\]. One drawback of the Cu-catalyzed cycloaddition of alkynylbismuthanes is the requirement of alkyne derivatives based on the phenothiabismuthane 5,5-dioxide framework for stabilization. The utility of organoantimony compounds in organic synthesis has attracted much interest during the last two decades \[[@R25]--[@R26]\]. Trivalent organoantimony compounds (stibanes) such as aryl- and ethynylstibanes are useful transmetalation agents in Pd-catalyzed cross-coupling reactions with aryl halides and acyl chlorides \[[@R27]--[@R32]\]. Stibanes have many advantages such as the handle ability without special care, low toxicity, and availability. Therefore, the synthesis and reactivity of novel stibanes are important for the development of effective organic reagents. However, to the best of our knowledge, there have been no reports concerning the synthesis of 1,4,5-trisubstituted 5-stibano-1,2,3-triazoles. Herein, we report a novel CuAAC of a simple alkynylstibane, (phenylethynyl)di-*p*-tolylstibane, with organic azides to form fully substituted 5-organostibano-1,2,3-triazoles.

Results and Discussion
======================

We initially determined the optimal experimental conditions for the cycloaddition of (phenylethynyl)di-*p*-tolylstibane (**1**) with benzylazide (**2a**) under aerobic conditions. [Table 1](#T1){ref-type="table"} summarizes the reaction yields obtained with various catalysts and solvents. We first examined the reaction of **1** (0.5 mmol) with **2a** (0.5 mmol) using 5 mol % of various Cu catalysts under aerobic conditions in THF at 60 °C ([Table 1](#T1){ref-type="table"}, entries 1--9). The results showed that CuBr was the best catalyst and gave the highest yield of the expected 5-stibano-1,2,3-triazole **3a** ([Table 1](#T1){ref-type="table"}, entry 2). The reaction without the Cu catalyst did not afford **3a** ([Table 1](#T1){ref-type="table"}, entry 10). Screening of solvents showed that the reaction proceeds effectively in THF (93%) and 1,4-dioxane, whereas DMSO, DMF, EtOH, toluene and 1,2-DCE gave inferior results ([Table 1](#T1){ref-type="table"}, entries 11--17). The best result was obtained when **1** was treated with **2a** using a catalytic amount of CuBr in THF at 60 °C. This cycloaddition could also be scaled up to 10 mmol and the desired product **3a** was obtained in excellent yields of up to 95%, i.e., 5.11 g of the product could be generated. When Cu(OAc)~2~ was employed as catalyst, 1-benzyl-4-phenyltriazole **4** was isolated in 83% yield as the major product ([Table 1](#T1){ref-type="table"}, entry 7). Heating of 5-stibano-1,2,3-triazole **3a** in the presence of Cu(OAc)~2~ (5 mol %) under aerobic conditions in THF at 60 °C for 3 h afforded **4** in 91% yield. Furthermore, heating of **1** without **2a** under the same conditions did not give the phenylacetylene and the starting compound was recovered (84%). These two experiments indicate that the formation of 5-*H*-triazole **4** progresses via 5-stibanotriazole **3a**, the cycloaddition product of **1** with **2a**.

###### 

Cu-catalyzed reaction of ethynylstibane **1** with benzylazide **2a** ^a^.

  -------------------------------------------- ------------ ------------- ---------------- ----
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  Entry                                        Cu cat.      Solvent       Yield \[%\]^b^   
                                                                                           
  **3a**                                       **4**                                       
                                                                                           
  1                                            CuI          THF           76               10
  2                                            CuBr         THF           93               3
  3                                            CuCl         THF           61               19
  4                                            CuOAc        THF           18               30
  5                                            Cu~2~O       THF           25               26
  6                                            CuBr~2~      THF           49               12
  7                                            Cu(OAc)~2~   THF           9                83
  8                                            CuO          THF           9                8
  9                                            CuSO~4~      THF           9                30
  10                                           --           THF           --               2
  11                                           CuBr         1,4-dioxane   61               17
  12                                           CuBr         CH~3~CN       46               42
  13                                           CuBr         DMSO          32               56
  14                                           CuBr         1,2-DCE       18               28
  15                                           CuBr         EtOH          18               14
  16                                           CuBr         DMF           12               83
  17                                           CuBr         toluene       6                3
  -------------------------------------------- ------------ ------------- ---------------- ----

^a^Reaction conditions: **1** (0.5 mmol), **2a** (0.5 mmol), Cu cat. (0.025 mmol). ^b^Isolated yield.

To investigate the scope and limitations of the CuAAC reaction of stibane, ethynylstibane **1** was reacted with a series of organic azides **2** under optimized conditions (CuBr/THF/60 °C). The results are summarized in [Scheme 1](#C1){ref-type="fig"}. Organic azides having functional groups such as *o*-bromobenzyl, 1-naphthalenemethyl, 2-phenylethyl, (ethoxycarbonyl)methyl, cinnamyl, (phenylthio)methyl and (phenylseleno)methyl afforded the corresponding products **3b--h** in good to excellent yields. In the case of the reaction with *o*-bromobenzyl azide, the carbon--bromine bond of **3b** remained intact, and other byproducts were not observed. Azides containing a linear alkyl group, acetal moiety, and a heteroaromatic ring such as pyridine gave the corresponding triazoles **3i--k** in moderate yields. The CuAAC reaction of **1** with aryl azides such as 4-methylphenyl and 4-cyanophenyl azide gave a complex mixture, presumably due to the steric hindrance introduced by the aryl groups.

![Copper-catalyzed \[3 + 2\] cycloaddition of **1** with organic azides **2**. Reaction conditions: **1** (0.5 mmol), **2a** (0.5 mmol), Cu cat. (0.025 mmol). Isolated yield are shown.](Beilstein_J_Org_Chem-12-1309-g003){#C1}

The regiochemistry of 5-stibanotriazole **3a** was elucidated by ^1^H NMR and confirmed by single-crystal X-ray analysis ([Fig. 1](#F1){ref-type="fig"}). A nuclear Overhauser effect (NOE) was observed between the benzyl protons and the aromatic protons of the antimony *p*-tolyl groups. Other triazole **3** showed similar NOE signals between the 1-*N*-substituent protons and the *p*-tolyl protons.

![Ortep drawing of **3a** with 50% probability. All hydrogen atoms are omitted for clarity. Two independent molecules exist in the asymmetric unit, one of them is shown.](Beilstein_J_Org_Chem-12-1309-g002){#F1}

The reaction mechanism of the cyclization is unclear at present. We consider that the catalytic cycle of this reaction would be similar to that for the reaction of 1-iodoalkynes \[[@R21],[@R33]\] and 1-bismuthanoalkynes \[[@R24]\] with organic azides. A possible mechanism of the present Cu-catalyzed cycloaddition is shown in [Scheme 2](#C2){ref-type="fig"}. Initially, π-complex **A** is generated by the reaction of the Cu(I) catalyst and ethynylstibane **1**. Complex **A** coordinates with an organic azide to give complex **B**. Cyclization proceeds via a vinylidene-like transition state **C** to give 5-stibanotriazole **3**.

![Possible mechanism.](Beilstein_J_Org_Chem-12-1309-g004){#C2}

To test the reactivity of 5-stibanotriazole **3a** was treated with hydrochloric acid, halogens, and nitrosyl tetrafluoroborate (NOBF~4~) ([Scheme 3](#C3){ref-type="fig"}). The deantimonation of **3a** with HCl gave 1-benzyl-4-phenyl-1,2,3-triazole (**4**) in 98% yield. Iodination of **3a** using I~2~ afforded 5-iodo-4-phenyl-1,2,3-triazole (**5**) in 71% yield. However, the reaction of **3a** with Br~2~ gave a complex mixture. The reaction of **3a** with NOBF~4~ afforded pentavalent organoantimony compound **6** in 85% yield. It is noteworthy that 5-bismuthanotriazole was demetallated upon reaction with NOBF~4~ to give the corresponding 5-nitroso compound \[[@R24]\].

![Reaction of **3a** with HCl, I~2~ and NOBF~4~.](Beilstein_J_Org_Chem-12-1309-g005){#C3}

Conclusion
==========

In conclusion, the Cu-catalyzed azide--alkyne cycloaddition of (phenylethynyl)di-*p*-tolylstibane with organic azides afforded novel 1,4,5-trisubstituted 5-organostibano-1*H*-1,2,3-triazoles, which could be further derivatized using I~2~ and NOBF~4~. Studies on the cycloaddition of diversely-functionalized ethynylstibanes and functionalization at the 5-position of 5-stibanotriazole by electrophilic substitution and cross-coupling reaction are in progress.

Experimental
============

**General procedure for the preparation of compounds 3:** CuBr (3.6 mg, 0.025 mmol, 5 mol %), (phenylethynyl)di-*p*-tolylstibane (**1**, 203 mg, 0.5 mmol), and an organic azide (**2**, 0.5 mmol) were dissolved in THF (5 mL). The reaction mixture was stirred at 60 °C and monitored by TLC. Upon disappearance of the starting materials, the reaction mixture was diluted with CH~2~Cl~2~ (30 mL) and water (20 mL). The phases were separated and the aqueous layer was extracted with CH~2~Cl~2~ (20 mL × 2). The combined organic layers were washed 5% aqueous ammonia and water, dried over MgSO~4,~ and concentrated under reduced pressure. The residue was purified by silica gel chromatography (*n*-hexane:AcOEt) to give **3b**, **3i** (8:1), **3f** (6:1), **3g**, **3h** (5:1), **3c**, **3d**, **3e**, **3j** (4:1), **3k** (1:1).
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======================
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Experimental procedures, full compound characterisation data and X-ray crystallographic data.
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